Delivery Order SPE2DR25D1100-SPE2DR26FCV4N
Award Date 12/17/25
Potential Completion Date 12/18/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This firm fixed price delivery order, valued at $1,041.62, represents a non-competitive set-aside award under DLA's pharmaceutical supply chain. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injection on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-competitive, firm fixed-price delivery order represents a single shipment of the GLP-1 receptor agonist medication used for weight management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $27,024.85 delivery order on December 4, 2025, for Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order employs firm fixed-price pricing with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $50,540.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on December 16, 2025, with completion scheduled for December 17, 2025. This competitively awarded, firm fixed-price delivery order represents a specific pharmaceutical procurement from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,845.70 on November 25, 2025, for Zepbound 7.5 mg/0.5 mL pen (a GLP-1 receptor agonist medication used for weight management). This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $1,476.56 to supply Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 12, 2025. AmerisourceBergen will perform the work at its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,764.57 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injectors on November 18, 2025, with completion required by November 19, 2025. This competitive award, issued without set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,515.04 to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 ml pen (0.5 ml), a pharmaceutical product used in diabetes and weight management treatment. The contract, designated as a firm fixed-price delivery order with no set-aside provisions, was awarded on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place...